Phathom amends bylaws to adopt universal proxy rules and enhance stockholder nomination disclosures

Phathom Pharmaceuticals, Inc.

Amended bylaws require compliance with SEC Rule 14a-19 for proxy solicitations supporting non-Board nominees.
Enhanced disclosure requirements for stockholders nominating directors or submitting proposals at meetings.
Changes effective December 13, 2023; also includes technical and modernizing updates.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Phathom Pharmaceuticals, Inc.: Amended and restated bylaws to address universal proxy rules, enhance procedural mechanics for stockholder nominations and proposals, and make technical updates (effective 2023-12-13).

Change: bylaw amendment
Effective: 2023-12-13

Exact text from the filing

On December 13, 2023, the Board of Directors (the “Board”) of Phathom Pharmaceuticals, Inc. (the “Company”) approved and adopted amended and restated bylaws (the “Amended and Restated Bylaws”), which became effective the same day.

View on SEC.gov

Browse all governance changes →

Phathom Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-296630

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.